PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

HPV vaccine prevents most cervical cancer cases in more deprived groups, major study shows

2024-05-16
(Press-News.org) Strict embargo: 23.30 hrs BST  Wednesday, 15 May, 2024  Peer-reviewed

Observational

People

  The human papillomavirus, or HPV, vaccine is cutting cases of cervical cancer right across the socio-economic spectrum, with most cases being prevented in more deprived groups, according to a major study funded by Cancer Research UK. 

Until now, there had been concerns that the HPV vaccine could have an unequal impact across society. After carrying out the longest follow-up on the effectiveness of the HPV vaccine, researchers at Queen Mary University of London concluded the HPV vaccination programme in England is helping to close some inequalities in cervical cancer. * 

Due to a typically higher incidence of cervical cancer in more deprived groups, researchers found that more cases were prevented in the most deprived group (around 190), compared to the least deprived group (around 60). ** 

Published in the BMJ medical journal, the data reflected the huge success of the school-based vaccination programme, showing that well-executed public health interventions can help to reduce health inequalities. 

Today’s news adds even more weight to evidence that HPV vaccination works. Researchers found that over a 12-year period, the vaccine reduced cervical cancer incidence rates by nearly 90% and pre-cancerous conditions by around 95% in women who were offered routine vaccination at 12-13 years old in England. The study shows that the vaccine is much more effective when taken up by people in year 8 (aged 12-13) than later in life. 

Although the life-saving HPV vaccine currently reaches people from all backgrounds, Cancer Research UK warns that some inequalities remain in cervical cancer incidence, and more work is needed to improve the health of the most deprived groups. Uptake of the HPV vaccine in the UK has also fallen in recent years.  

Overall, cervical cancer rates are higher in people from deprived backgrounds across the UK. Researchers said this is partly due to people being at greater risk from HPV and barriers that can drive lower screening attendance.  

Professor Peter Sasieni, lead author from Queen Mary University of London, said: 

“Our research highlights the power of HPV vaccination to benefit people across all social groups.  

“Historically, cervical cancer has had greater health inequalities than almost any other cancer and there was concern that HPV vaccination may not reach those at greatest risk. Instead, this study captures the huge success of the school-based vaccination programme in helping to close these gaps and reach people from even the most deprived communities.  

“In the UK, the elimination of cervical cancer as a public health problem in our lifetime is possible with continued action to improve access to vaccination and screening for all.” 

The HPV vaccine, combined with cervical screening, can dramatically reduce cervical cancer incidence to the point where almost no one develops it. Improving people’s access to both programmes is at the heart of NHS England’s recent pledge to eliminate cervical cancer as a public health problem by 2040. *** 

This research, however, lands when uptake of the HPV vaccine and screening attendance has fallen in recent years across the UK and coverage rates are yet to recover from the disruption of the COVID pandemic.  

With huge progress in tackling cervical cancer at risk of stalling, Cancer Research UK is encouraging all eligible people to take up the offer of vaccination and screening. The charity is also calling on the UK Government to ensure both programmes in England are backed by sufficient resources and modern IT infrastructure. 

Cancer Research UK’s senior health information manager, Sophia Lowes, said: 

“Every year, around 3,300 people receive a cervical cancer diagnosis in the UK. This research shows us that HPV vaccination works, and increased coverage can help to bring about a future virtually free from this disease. 

"But we can't lose momentum. We're calling for targeted action to ensure that as many young people as possible get the lifesaving HPV vaccine. Better reporting on uptake by deprivation and ethnicity, along with more research, will help us understand how to reach those most at risk. 

"We encourage people to take up the HPV vaccine if they are eligible. If you are concerned that you or your child has missed out on the HPV vaccine, you can contact your child’s school nurse, school immunisation service or GP surgery to find out more." 

Cancer Research UK scientists helped to prove the link between HPV and cervical cancer 25 years ago. This discovery put the gears in motion for the HPV vaccination programme and improved cervical cancer screening. Thanks to these scientific developments, cervical cancer rates in the UK have fallen by almost a third since the early 1990s. **** 

The HPV vaccination programme was first introduced to England in 2008. Since then, girls aged 11-13 in the UK have been offered the vaccine and since September 2019, boys of the same age can also get it. Anyone who missed their vaccine can request it through the NHS up to the age of 25.  

It’s also available to men who have sex with men and some transgender people up to the age of 45 through sexual health and HIV clinics. 

Cancer Research UK chief executive, Michelle Mitchell OBE, said:  

“Today’s news is promising – the HPV vaccination programme is paving the way to make cervical cancer a rare disease for all.

“The UK Government and the NHS must continue to work with communities and services, so the HPV vaccine is taken up by as many eligible people as possible, and accurate information reaches those who most need it. 

“We want to see a world where everyone shares in this scientific and research progress equally.” 



ENDS 

CRUK spokespeople and study researchers are available for interview. Case study information is available upon request. For media enquiries please contact Anna Cawdron in the Cancer Research UK press office on 020 3469 8928 and anna.cawdron@cancer.org.uk or via press out of hours, 020 3469 8301. 

Notes to editor:

* Embargoed link to research: http://press.psprings.co.uk/bmj/may/HPV.pdf  

Public link once embargo lifts: https://www.bmj.com/content/385/bmj-2023-077341  

The study was conducted by researchers at Queen Mary University of London, together with colleagues at the UK Health Security Agency and NHS England. In the longest timeframe to date, researchers looked at pre-cancerous and invasive cervical cancers diagnosed in England in women aged 20-64 between 2006 and mid-2020.

To represent socio-economic deprivation, researchers used the Index of Multiple Deprivation (IMD). This is a small-area measure based on several domains of deprivation (e.g. income, employment, health and crime). 

** This study included approximately 650,000 people offered vaccination aged 12-18 in each of the five deprivation groups. 

*** Nearly all cases of cervical cancer are caused by HPV. HPV infects the skin and cells lining the inside of the body. Most people, regardless of gender, will have HPV at some point in their lifetime and the infection usually gets better on its own. For every 100 people who attend cervical screening, around 13 people will receive a positive HPV result. If left untreated, these HPV infections can sometimes lead to cancer. This process takes many years.   

The HPV vaccine protects against the main cancer-causing strains of the virus, and some strains which cause genital warts. Vaccinating people against the infection helps to prevent abnormal changes in cervical cells, in turn leading to fewer cases of cervical cancer.   

In the UK, cervical screening tests for high-risk strains of HPV, and if it is detected, looks for abnormal cell changes. By finding and treating these changes, it aims to prevent cervical cancer from developing. The screening programme is for women, some transgender men and some non-binary people – everyone with a cervix. In the UK it’s offered to those aged 25 to 64.

**** Based on the percentage change in incidence rates from 14 cases per 100,000 women in the UK between 1991-1993 to 10 cases per 100,000 women between 2017-2019. 

Cancer Research UK also funds research to ensure more people in low- and middle- income countries can be fully vaccinated against HPV. Around 90% of cases and deaths from cervical cancer occur in low and middle-income countries due to limited access to vaccination, screening, and treatment options. 

Information about NHS England’s pledge to eliminate cervical cancer by 2040 can be found here.  NHS guidance on HPV vaccination can be found here, and cervical screening here. Previous research on the effectiveness of the HPV vaccine can be found here.  ​

About Cancer Research UK:  

Cancer Research UK is the world’s leading cancer charity dedicated to saving lives through research, influence and information.  Cancer Research UK’s pioneering work into the prevention, diagnosis and treatment of cancer has helped save millions of lives.   Cancer Research UK has been at the heart of the progress that has already seen survival in the UK double in the last 50 years.   Today, 2 in 4 people survive their cancer for at least 10 years. Cancer Research UK wants to accelerate progress and see 3 in 4 people surviving their cancer by 2034.  Cancer Research UK supports research into the prevention and treatment of cancer through the work of over 4,000 scientists, doctors and nurses.  Together with its partners and supporters, Cancer Research UK is working towards a world where people can live longer, better lives, free from the fear of cancer.  For further information about Cancer Research UK's work or to find out how to support the charity, please call 0300 123 1022 or visit www.cancerresearchuk.org. Follow us on Twitter and Facebook 

END



ELSE PRESS RELEASES FROM THIS DATE:

Radiation-based immunogenic vaccine combined with a macrophage “checkpoint inhibitor” for boosting innate and adaptive immunity against metastatic colon cancers

2024-05-15
https://doi.org/10.1016/j.apsb.2024.02.015   This new article publication from Acta Pharmaceutica Sinica B, discusses how the use of a radiation-based immunogenic vaccine combined with a macrophage “checkpoint inhibitor” can boost innate and adaptive immunity against metastatic colon cancers.   Immunogenic dying tumor cells hold promising prospects as cancer vaccines to activate systemic immunity against both primary and metastatic tumors. Especially, X-ray- induced dying tumor cells are rich in highly immunogenic tumor-associated antigens ...

Branched glycopolymer prodrug-derived nanoassembly combined with a STING agonist activates an immuno-supportive status to boost anti-PD-L1 antibody therapy

2024-05-15
https://doi.org/10.1016/j.apsb.2024.02.006   This new article publication from Acta Pharmaceutica Sinica B, discusses how branched glycopolymer prodrug-derived nanoassembly combined with a STING agonist activates an immuno-supportive status to boost anti-PD-L1 antibody therapy.   Despite the great potential of anti-PD-L1 antibodies for immunotherapy, their low response rate due to an immunosuppressive tumor microenvironment has hampered their application.   To address this issue, the authors of this article constructed a cell membrane-coated nanosystem (mB4S) to reverse an immunosuppressive microenvironment to an immuno-supportive ...

5S-Heudelotinone alleviates experimental colitis by shaping the immune system and enhancing the intestinal barrier in a gut microbiota-dependent manner

2024-05-15
https://doi.org/10.1016/j.apsb.2024.02.020   This new article publication from Acta Pharmaceutica Sinica B, discusses how 5S-Heudelotinone alleviates experimental colitis by shaping the immune system and enhancing the intestinal barrier in a gut microbiota-dependent manner.   Aberrant changes in the gut microbiota are implicated in many diseases, including inflammatory bowel disease (IBD). Gut microbes produce diverse metabolites that can shape the immune system and impact the intestinal barrier integrity, indicating that microbe-mediated modulation may be a promising strategy for preventing and treating IBD.   Although ...

ALS-linked C9orf72 dipeptide repeats inhibit starvation-induced autophagy through modulating BCL2–BECN1 interaction

2024-05-15
https://doi.org/10.1016/j.apsb.2024.02.004   This new article publication from Acta Pharmaceutica Sinica B, discusses how ALS-linked C9orf72 dipeptide repeats inhibit starvation-induced autophagy through modulating BCL2–BECN1 interaction.   Growing evidence indicate that dysfunction of autophagy contributes to the disease pathogenesis of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), two neurodegenerative disorders. The GGGGCC·GGCCCC repeat RNA expansion in chromosome 9 open reading frame 72 (C9orf72) ...

Carbon-capture batteries developed to store renewable energy, help climate

Carbon-capture batteries developed to store renewable energy, help climate
2024-05-15
Researchers at the Department of Energy’s Oak Ridge National Laboratory are developing battery technologies to fight climate change in two ways, by expanding the use of renewable energy and capturing airborne carbon dioxide.  This type of battery stores the renewable energy generated by solar panels or wind turbines. Utilizing this energy when wind and sunlight are unavailable requires an electrochemical reaction that, in ORNL’s new battery formulation, captures carbon dioxide from industrial emissions and converts it to value-added products.   ORNL researchers recently created and tested two different formulations for batteries that ...

From roots to resilience: investigating the vital role of microbes in coastal plant health

From roots to resilience: investigating the vital role of microbes in coastal plant health
2024-05-15
Georgia’s saltwater marshes — living where the land meets the ocean — stretch along the state’s entire 100-mile coastline. These rich ecosystems are largely dominated by just one plant: grass. Known as cordgrass, the plant is an ecosystem engineer, providing habitats for wildlife, naturally cleaning water as it moves from inland to the sea, and holding the shoreline together so it doesn’t collapse. Cordgrass even protects human communities from tidal surges. Understanding how these ...

Q&A: How did the COVID-19 pandemic affect older adults’ technology use?

2024-05-15
The onset of the COVID-19 pandemic changed how nearly everyone mediated their social interactions through technology. Some moved happy hours into video chats. Others delved deeper into social media, or took a step back from it. Millions of people worked or learned through computers. University of Washington researchers took particular interest in how this tech shift affected older adults’ social relationships. The team interviewed 16 older adults in Washington and Oregon, ages 65 to 80, about how their technology ...

Blood pressure drugs more than double bone-fracture risk in nursing home patients

2024-05-15
Records from nearly 30,000 nursing home residents indicate that blood pressure medications more than double the risk of life-threatening bone fractures, according to Rutgers Health research. The authors of the study, which appears in JAMA Internal Medicine, said the increased risk stems from the medications’ tendency to impair balance, particularly when patients first stand up and temporarily experience low blood pressure that deprives the brain of oxygen. Interactions with other drugs and low baseline balance in many nursing home patients compound the problem. “Bone fractures often start nursing home patients on a downward spiral,”  ...

Regenerating worms have genetic control over their algal partners

Regenerating worms have genetic control over their algal partners
2024-05-15
Many organisms are far more complex than just a single species. Humans, for example, are full of a variety of microbes. Some creatures have even more special connections, though. Acoels, unique marine worms that regenerate their bodies after injury, can form symbiotic relationships with photosynthetic algae that live inside them. These collections of symbiotic organisms are called a holobiont, and the ways that they “talk” to each other are something scientists are trying to understand – especially ...

Pre- and post-surgical immunotherapy improves outcomes for patients with operable lung cancer

Pre- and post-surgical immunotherapy improves outcomes for patients with operable lung cancer
2024-05-15
Compared with pre-surgical (neoadjuvant) chemotherapy alone, adding perioperative immunotherapy – given before and after surgery – significantly improved event-free survival (EFS) in patients with resectable early-stage non-small cell lung cancer(NSCLC), according to researchers from The University of Texas MD Anderson Cancer Center. Results from the Phase III CheckMate 77T study were published today in the New England Journal of Medicine. At a median follow-up of 25.4 months, the median EFS with chemotherapy alone was 18.4 months, while the median had not yet ...

LAST 30 PRESS RELEASES:

Nucleoporin93: A silent protector in vascular health

Can we avert the looming food crisis of climate change?

Alcohol use and antiobesity medication treatment

Study reveals cause of common cancer immunotherapy side effect

New era in amphibian biology

Harbor service, VAST Data provide boost for NCSA systems

New prognostic model enhances survival prediction in liver failure

China focuses on improving air quality via the coordinated control of fine particles and ozone

Machine learning reveals behaviors linked with early Alzheimer’s, points to new treatments

Novel gene therapy trial for sickle cell disease launches

Engineering hypoallergenic cats

Microwave-induced pyrolysis: A promising solution for recycling electric cables

Cooling with light: Exploring optical cooling in semiconductor quantum dots

Breakthrough in clean energy: Scientists pioneer novel heat-to-electricity conversion

Study finds opposing effects of short-term and continuous noise on western bluebird parental care

Quantifying disease impact and overcoming practical treatment barriers for primary progressive aphasia

Sports betting and financial market data show how people misinterpret new information in predictable ways

Long COVID brain fog linked to lung function

Concussions slow brain activity of high school football players

Study details how cancer cells fend off starvation and death from chemotherapy

Transformation of UN SDGs only way forward for sustainable development 

New study reveals genetic drivers of early onset type 2 diabetes in South Asians 

Delay and pay: Tipping point costs quadruple after waiting

Magnetic tornado is stirring up the haze at Jupiter's poles

Cancers grow uniformly throughout their mass

Researchers show complex relationship between Arctic warming and Arctic dust

Brain test shows that crabs process pain

Social fish with low status are so stressed out it impacts their brains

Predicting the weather: New meteorology estimation method aids building efficiency

Inside the ‘swat team’ – how insects react to virtual reality gaming 

[Press-News.org] HPV vaccine prevents most cervical cancer cases in more deprived groups, major study shows